Product ID:35332 XYLOCAINE SOLUTIONS WITH EPINEPHRINE
MSDS Date:09/01/1987
FSC:6505
NIIN:01-146-1139
MSDS Number: BZNKZ

ASTRA PHARMACEUTICAL PRODUCTS INC

50 OTIS ST
WESTBOROUGH, MA 01581-3323
US

Emergency Phone: 800-225-6333/508-366-1100

Info Phone: 508-366-1100/800-225-6333

Cage: 04473

ASTRA PHARMACEUTICAL PRODUCTS INC

WESTBOROUGH, MA 01581-3323 US

Telephone: 508-366-1100/800-225-6333

Cage: 04473

2-DIETHYLAMINO-2',6'-ACETOXYLIDIDE (LIDOCAINE

CAS: 73-78-9

RTECS: AN7600000

Fraction By Weight: 0.5-2.0%

EPINEPHRINE (CERCLA)

CAS: 51-43-4

RTECS: DO2625000

Fraction By Weight: <0.0011%

EPA Report Quantity: 1000 LBS

DOT Report Quantity: 1000 LBS

LD50 LC50 Mixture:PRODUCT'S LD50 (ORAL RAT) WAS NOT STATED
Routes of Entry: Inhalation:NO Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INGESTION & SYSTEMIC ABSORPTION:TOXIC
EFFECTS OF CNS & CARDIOVASCULAR SYSTEM. ALLERGIC REACTIONS MAY
OCCUR. ADVERSE EFFECTS ON INTACT SKIN ARE UNLIKELY. CONTACT
W/MUCOUS MEMBRANES MAY CAUSE IRRITATION . CONTACT W/THE EYE MAY
CAUSE IRRITATION. EYE CONTACT WILL ALSO CAUSE NUMBNESS & LOSS OF
SENSATION.
Explanation of Carcinogenicity:NOT LISTED.
Effects of Overexposure:SYSTEMIC EFFECTS MAY INCLUDE NERVOUSNESS,
CONFUSION, DROWSINESS, BLURRED VISION, VOMITING, TREMORS,
CONVULSIONS, RESPIRATORY DEPRESSION, SLOWING OF THE HEART, BLOOD
PRESSURE DROP & UNCONSCIOUSNESS.
Medical Cond Aggravated by Exposure:HYPERSENSITIVITY TO LOCAL
ANESTHETICS OF THE AMIDE TYPE.

First Aid:CALL A PHYSICIAN. MEDICAL ATTENTION SHOULD INCLUDE
MAINTENANCE OF BREATHING & CONTROLLING CONVULSIONS IF THEY OCCUR.
IF EYE CONTACT OCCURS, WASH THOROUGHLY W/CLEAN WATER FOR 15
MINUTES.

Flash Point:NOT FLAMMABLE
Fire Fighting Procedures:NONE
Unusual Fire/Explosion Hazard:NONE

Spill Release Procedures:CLEAN UP SPILLS WITH NORMAL PROCEDURE USED FOR
NON-HAZARDOUS LIQUIDS.
Neutralizing Agent:MFR GAVE NO INFORMATION OF MSDS.

Handling and Storage Precautions:STORE IN A COOL, DRY PLACE. AVOID
EXTREMES OF TEMPERATURE. HANDLE TO AVOID BREAKAGE.
Other Precautions:NO PRECAUTIONARY LABELING REQUIRED. CAUTION AGAINST
INGESTION & CONTADT W/THE EYES IS RECOMMENDED. SUBJECT TO DAMAGE BY
FREEZING.

Respiratory Protection:NONE NORMALLY REQUIRED
Ventilation:USE LOCAL EXHAUST.
Protective Gloves:NONE NORMALLY REQUIRED
Eye Protection:NONE NORMALLY REQUIRED
Other Protective Equipment:NONE NORMALLY REQUIRED
Work Hygienic Practices:MFR GAVE NO INFORMATION OF MSDS.
Supplemental Safety and Health
NONE

HCC:N1
NRC/State Lic Num:NONE
Boiling Pt:B.P. Text:212F,100C
Melt/Freeze Pt:M.P/F.P Text:32.0F,0.0C
Vapor Pres:17
Vapor Density:0.6
Spec Gravity:1
Evaporation Rate & Reference:1 (WATER = 1)
Solubility in Water:SOLUBLE
Appearance and Odor:CLEAR, ODORLESS LIQUID

Stability Indicator/Materials to Avoid:YES
COMPOUNDS WHICH REACT VIOLENTLY WITH WATER
Stability Condition to Avoid:NONE
Hazardous Decomposition Products:NONE

Waste Disposal Methods:DISPOSE AS A NON-HAZARDOUS WASTE.
(DLA-HMIS:I/A/W FEDERAL, STATE & LOCAL REGULATIONS.)

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.